Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine effects on ropivacaine pharmacokinetics and pharmacodynamics in lumbar plexus block
ChiCTR1900023934Phase 4Recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jun 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and ropivacaine (5 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Pharmacokinetics assessment. Started Jun 2019; status: recruiting.
02
Drugs
dexmedetomidineropivacaine
Beyond the preview
Go deeper on ChiCTR1900023934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023934.